There are some ASX tech shares that could be worth watching in 2021.

The next 12 months could be another interesting period with COVID-19 still impacting the world.

Here are those ASX tech share ideas:

Pushpay Holdings Ltd (ASX: PPH)

Pushpay is an electronic donation business. This year has seen accelerated growth during COVID-19 conditions of social distancing and restrictions. The main client base of Pushpay is large and medium US churches. Pushpay’s technology allows the churches to stay connected with the congregation, one of the tools it offers is a livestreaming service.

In the current financial year, Pushpay is looking to more than double its earnings before interest, tax, depreciation, amortisation and foreign currency (EBITDAF) to a range of US$54 million to US$58 million.

The combined offering from Pushpay and Church Community Builder (called ChurchStaq) is proving popular with clients as it offers all of the relevant tools under a single product.

Over the long-term Pushpay is aiming to grow its annual revenue to US$1 billion, with an aim to significantly increase its market share.

Pushpay expects “significant operating leverage to accrue as operating revenue continues to increase, while growth in total operating expenses remains low.” The company reported in its 2021 interim result that its gross profit margin grew from 65% to 68% and the EBITDAF margin went up from 17% to 31%.

The ASX tech share is now looking to expand with smaller churches across the US.

Fund manager Ben Griffiths from Eley Griffiths wrote about Pushpay: “Over the last 12 months it has become clear Pushpay is at an inflection point for both Fund cashflow and earnings. Under the stewardship of CEO Bruce Gordon, Pushpay has transitioned from a founder-led investment phase into an optimize/monetization phase. What is more surprising is the very conservative nature of the accounts (a rarity in small cap tech, outside Iress Ltd (ASX: IRE). We believe the next few years for Pushpay will be rewarding and that COVID-19 will accelerate the already entrenched trend to digital giving/engagement from cash.”

At the current Pushpay share price it’s valued at 25x FY23’s estimated earnings.

EML Payments Ltd (ASX: EML)

This ASX tech share has a number of different payment services for clients to use. EML Payments has general purpose reloadable offerings such as gaming payouts with white label gaming cards, salary packaging cards, commission payouts and rewards programs. EML Payments also offers physical gift cards, shopping centre gift cards and digital gift cards. Finally, it offers virtual account numbers.

A couple of months ago EML Payments gave an update for the first quarter of FY21 which showed strong growth and improving trading conditions. Historically, the first quarter is the weakest quarter of the year.

In that first quarter, EML Payments said its gross debit volume (GDV) was $4.85 billion, which was up 51% compared to the prior corresponding period and 20% higher than the prior quarter, being the fourth quarter of FY20.

The growth in GDV helped EML generate revenue of $40.6 million, which represented growth of 75% compared to the prior corresponding period and up 20% compared to the fourth quarter of FY20.

In terms of profitability, EML generated $10 million of EBITDA in the FY21 first quarter, up 215% compared to the prior corresponding period and up 69% compared to the FY20 fourth quarter.

Gift and incentive volumes recovered significantly in the first quarter after the COVID-19 impacts, general purpose reloadable volumes grew significantly and virtual account numbers recovered to pre-COVID levels.

More reading

• The ASX tech shares to buy in 2021
• Here are 6 of the top performing ASX fintech shares of 2020
• Can these ASX IT shares carry their momentum into 2021?
• 3 of the best ASX shares to buy in January
• 2 rapidly growing ASX tech shares to buy

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends EML Payments. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia has recommended EML Payments and PUSHPAY FPO NZX. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 ASX tech shares to buy for 2021 appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3o14ZAt

Cheap dividend stocks could offer more than just a high yield in 2021. In many cases, their financial positions and profit potential means that they could deliver a rising dividend in the coming years.

As such, now may be the right time to buy a selection of income shares with affordable dividends and improving financial prospects. They could provide a generous passive income in an era where other assets offer disappointing returns.

Selecting cheap dividend stocks with growth potential

Some cheap dividend stocks may face difficult futures at the present time. Risks such as coronavirus and political change could hold back their financial performances in the short run.

As such, it is important to assess their financial prospects before buying them. For example, companies with low debt levels and solid financial positions may find it easier to pay a rising dividend despite challenging operating conditions. Similarly, businesses that currently pay a modest proportion of their profit to shareholders as a dividend may have greater scope to raise their income payouts in 2021 and in the coming years.

Meanwhile, cheap dividend stocks with bright long-term futures may be among the most attractive means of generating a growing passive income. For example, companies that stand to benefit from the increasing digitisation of many industries, such as retail, could generate higher profitability that translates into a rising dividend.

Managing risk for a sustainable passive income

Of course, an uncertain economic outlook means that buying a selection of cheap dividend stocks is arguably more important than ever. Investors who rely on a small number of companies for their income may find that their financial prospects are negatively impacted even if a small number of them struggle in 2021.

Diversifying across not only different industries, but also various regions, could be a shrewd move. The coronavirus pandemic is affecting different parts of the world to differing extents. Therefore, it could be a sound move to spread investment across dividend stocks that operate in multiple geographies. Doing so may limit the negative impact of challenging economic circumstances in localised areas caused by lockdown measures.

A long-term view

While obtaining a growing passive income via cheap dividend stocks is an achievable goal in 2021, taking a long-term view is still a good idea. It may take some of today’s most attractive income shares a number of years to deliver on their potential. Weak investor sentiment that makes them attractive purchases today due to their low valuations may take time to reverse in sectors that are currently struggling to grow sales and profitability.

As such, by taking a long-term view, it is possible to fully benefit from a likely economic recovery. Over time, this could lead to a fast-paced growth in passive income that improves an investor’s financial situation.

More reading

• Why the A2 Milk (ASX:A2M) share price is down 18.5% in 2020
• The U.K. authorizes AstraZeneca’s coronavirus vaccine for emergency supply
• Why the Wesfarmers (ASX:WES) share price is up 24% in 2020
• The BHP (ASX:BHP) share price has smashed the market in 2020
• Rain or shine for these 3 ASX agricultural shares

Motley Fool contributor Peter Stephens has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post How I’d make a growing passive income with cheap dividend stocks in 2021 appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3rJobVm

It has been an unusually disappointing year for the A2 Milk Company Ltd (ASX: A2M) share price.

After being up as much as 43% year to date at one stage, the a2 Milk share price is on course to record a 2020 decline of 18.5%.

Why has the a2 Milk share price bounced around in 2020?

Investors have been buying and then selling the company’s shares this year due to impacts from the COVID-19 pandemic.

At the height of the pandemic, a2 Milk was experiencing even more insatiable demand for its infant formula than normal due to panic buying and stockpiling.

This ultimately led to the company reporting a 32.8% increase in revenue to NZ$1,730 million and a 34.1% jump in net profit after tax to NZ$385.8 million in FY 2020.

Also coming in strongly was A2 Milk Company’s free cash flow. It generated operating cash flow of NZ$427.4 million, which led to it ending the period with a closing cash balance of NZ$854.2 million.

What went wrong?

However, since then, things haven’t gone quite to plan for the company and the tailwinds it was experiencing quickly became headwinds.

With many pantries stocked full of infant formula, demand for its key product softened. But the biggest impact was felt in the daigou channel because of the sudden closure of international borders, which meant no Chinese tourists hitting Australian shores and sending products back to the mainland.

The weakness in this particular channel was the reason for a2 Milk’s recent earnings guidance downgrade and means the former market darling is expecting to post a notable reduction in both sales and earnings in FY 2021.

Anything else?

Also weighing on investor sentiment this year was news that many of the company’s executives had sold a large number of shares.

For example, the company’s Chair and Non-Executive Director, David Hearn, offloaded 250,000 of the company’s shares through an on market trade on 24 August for an average of NZ$20.31 per share (~A$18.57). This represents a total consideration of NZ$5,077,500 or approximately A$4,642,500.

This compares to the a2 Milk 52-week high of NZ$21.74 and today’s share price of NZ$12.05.

It certainly was great timing on management’s part. Mr Hearn’s 250,000 shares would be worth a touch over NZ$3 million today, which is NZ$2 million less than the Chair received for them.

More reading

• What next for the a2 Milk (ASX:A2M) share price?
• 2 of the best ASX 50 shares to buy today
• Why a2 Milk, Adacel, Dusk, & Nuheara shares are charging higher
• Top brokers name 3 ASX shares to buy next week
• These were the best performers on the ASX 200 last week

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the A2 Milk (ASX:A2M) share price is down 18.5% in 2020 appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3pC73iF

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

On Wednesday morning, the U.K. authorized AstraZeneca‘s (NASDAQ: AZN) coronavirus vaccine candidate for emergency supply. The first doses of COVID-19 Vaccine AstraZeneca (formerly known as AZD1222) will be released today with the intention to begin vaccinations early in the new year.

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) recommends two full doses given four to 12 weeks apart. This is the dosing regimen that appeared 62% effective in clinical trials in the U.K. and Brazil.

You may remember an unintentionally administered half-dose/full-dose regimen that appeared more than 90% effective in a smaller group of patients. Unfortunately, data available to the MHRA wasn’t sufficient to persuade the agency to deviate from the two full doses received by the vast majority of clinical trial participants.

The European Medicines Agency (EMA) and the Food and Drug Administration aren’t on the same page as the MHRA. As a result, timelines for similar authorizations for AstraZeneca are still fuzzy. 

On Tuesday, EMA executive director Noel Wathion told reporters that AstraZeneca hasn’t even filed an application yet. While AstraZeneca has sent in some data, it hasn’t been enough to warrant a conditional marketing license.

In the U.S., COVID-19 Vaccine AstraZeneca’s path forward is going to be bumpy. The company’s CEO has hinted at more-compelling clinical trial data to come, but the results we’ve seen so far don’t meet the FDA’s pre-determined efficacy threshold. Plus, the FDA has clearly stated it’s unwilling to authorize a candidate without some pivotal data from a U.S. study. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

More reading

• Could AstraZeneca be a millionaire-maker stock?

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post The U.K. authorizes AstraZeneca’s coronavirus vaccine for emergency supply appeared first on The Motley Fool Australia.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/37YhgQw

The Wesfarmers Ltd (ASX: WES) share price has been a very positive performer in 2020 and has smashed the market.

The conglomerate’s shares have rallied an impressive 24% higher since the turn of the year.

This compares to a small decline by the S&P/ASX 200 Index (ASX: XJO).

Why is the Wesfarmers share price zooming higher in 2020?

Investors have been buying Wesfarmers’ shares this year after it delivered a strong result in FY 2020 and continued this positive form in the new financial year.

For the 12 months ended 30 June 2020, the company reported a 10.5% increase in revenue from continuing operations to $30,846 million.

The key driver of this growth was its key Bunnings business. It was the star of the show in FY 2020 and recorded a 13.9% increase in sales to $14,996 million. Management advised that this was driven by solid demand for products during the pandemic after customers spent more time doing projects at home.

This was supported by its Kmart, Officeworks, and Catch businesses. Kmart recorded a 5.4% lift in sales to $6,068 million, Officeworks delivered a 20.4% lift in sales to $2,775 million, and Catch reported a big jump in sales to ~$600 million.

What about FY 2021?

The current financial year looks set to be equally successful for Wesfarmers.

A trading update in November reveals that it achieved strong sales growth across the business during the first four months of FY 2021.

Once again, the star of the show was the Bunnings business. It reported a 25.2% jump in sales during the period. As with FY 2020, this was driven partly by customers spending more time undertaking projects around the home.

Can the Wesfarmers share price go higher?

Although the Wesfarmers share price has been on fire this year, one leading broker still thinks it can go higher from here.

A recent note out of Credit Suisse reveals that its analysts have an outperform rating and $55.83 price target on its shares.

The broker has been looking at the household goods sector and believes the market is underestimating the boost to spending in this area due to more working from home. This led to Credit Suisse lifting its sales forecasts for the Bunnings and Officeworks businesses.

More reading

• 3 ASX shares that were unlikely winners in 2020
• 2 quality ASX dividend shares to buy
• Leading fund manager names the ASX dividend shares to buy in 2021
• Forget savings accounts and look at these quality ASX dividend shares
• 3 top ASX retail shares for your 2021 portfolio

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Wesfarmers (ASX:WES) share price is up 24% in 2020 appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3hCwtKk

The BHP Group Ltd (ASX: BHP) share price has been a positive performer in 2020.

Since the start of the year, the BHP share price has gained approximately 11%.

And if you add in the $1.75 per share dividends the company has paid during the 12 months, this gain stretches to over 15%.

This compares to a largely flat S&P/ASX 200 Index (ASX: XJO).

Why has the BHP share price outperformed in 2020?

The key driver of the company’s share price outperformance in 2020 has been a rise in the iron ore price. This has been driven by supply constraints in Brazil and robust demand in China as it spends big on infrastructure to reignite its economy.

Given the significant contribution that iron ore makes to its overall profits, a surging iron ore price is a huge positive for BHP.

At the time of writing, the spot iron ore price is fetching US$159.85 a tonne. While this has slipped from its recent highs, it is still around 70% higher than where it started the year.

It is also materially higher than what BHP pays to pull the steel making ingredient out of the ground.

The Big Australian has provided cost guidance of US$13 to US$14 a tonne for its iron ore operations in FY 2021. This means it will be generating high levels of free cash flow right now.

And given the strength of the company’s balance sheet, this is likely to lead to very generous dividend payments next year.

What else is support the BHP share price?

It isn’t just iron ore that is supporting the BHP share price.

Also rising this year was the copper price. The base metal is up strongly this year and has been trading at multi-year highs.

And while oil prices have been subdued, they are still trading at a level that make its petroleum business profitable.

Can its shares go higher?

One leading broker that believes there BHP share price can still go higher in 2021 is Ord Minnett.

Its analysts recently retained their buy rating and lifted the price target on its shares to $50.00.

The broker is also forecasting a fully franked ~$2.39 dividend in FY 2021. Based on the latest BHP share price of $43.14, this represents a 5.5% dividend yield.

More reading

• Will ASX iron ore shares continue running in 2021? 
• 5 things to watch on the ASX 200 on Wednesday
• ASX 200 up 0.65%: Big four banks rise, tech shares charge higher, Flight Centre jumps
• Leading fund manager names the ASX dividend shares to buy in 2021
• These ASX dividend shares could be top Christmas gifts for income investors

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post The BHP (ASX:BHP) share price has smashed the market in 2020 appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3o5FHB5

Growing up on a farm taught me many things, not the least of which was to appreciate a good downpour. As quoted from Tom Barret “If the rain spoils our picnic, but saves a farmer’s crop, who are we to say it shouldn’t rain?”. Lo and behold, I find myself looking at the Bureau of Meteorology’s 2021 forecast, even though I have no lawn – just a habit, I guess.

Agriculturally geared ASX shares have been just as sporadic with their performance as the rainfall. Let’s take a look at how these ag shares fared the 2020 storms.

Elders Ltd (ASX: ELD)

Elders provides a wide array of foundational agricultural goods and services, including livestock and wool agency services; and financial services for primary producers. The Elders share price has increased 52.24% in the last year, while also paying a dividend yielding 2.22% based on today’s price.

The retail products area of the company benefitted from a strong winter crop season. Product margins were substantially improved also by the sale of whole products through the acquisition of AIRR.

Agency services (acting as a broker in agricultural goods), experienced uplift from the strong prices for cattle and sheep.

Elders’ FY21 market outlook forecasts production to grow, but the value to hold steady as the price will reduce as a result of increased supply. However, the ongoing trade tensions with China leaves a question mark over the head of performance for 2021

Citigroup has a “buy” rating on Elders with a price target of $13.

Select Harvests Limited (ASX: SHV)

Select Harvests on the other hand has had a rough year. The agribusiness grows almond orchards; and processes and distributes an assortment of edible nuts, dried fruits, natural health foods, etc. The company has seen its share price fall 37.5% in the last year, from $8.34 to $5.21 at the time of writing. Where did it all go wrong?

Apparently, conditions were near perfect in the United States, leading to an oversupply – putting downwards pressure on almond prices. In addition to this, the company experienced shipment delays and record or near-record high spot prices for water across its operations.

The culmination of challenges led to Select Harvests’ earnings per share falling more than 53% for FY20.

CEO Paul Thompson mentioned in the September results that the improved weather conditions coming into the new financial year had moved water prices back towards long-term averages. However, the CEO declined to give a forecast for the 2021 crop.

Select Harvests market capitalisation stands at $633.98 million.

Nufarm Ltd (ASX: NUF)

It’s been a trialing year for the Melbourne based agricultural chemical company. The share price started out the year at $6.13, since then it has been a case of taking the stairs up and the elevator down – only the stairs go up 1 floor, and the elevator goes down 2. Currently, the share price sits at $4.26, having fallen 30.5% since the start of the year.

The company struggled through the dry seasons across multiple geographies, with large issues stemming from Europe. Nufarm noted that the European market is complex, it has much more cautionary regulations and the devalued currencies in those areas impacted the business.

Supply chain disruptions by COVID-19 also impacted the company’s ability to meet demand when more favourable weather arrived.

However, Nufarm showed in its Annual General Meeting Presentation that with improved weather conditions returning, all regions have improved in terms of revenue compared to the same time last year. This resulted in second half revenue for 2020 growing to $2,847 million, compared to $2,674 the previous year.

The recent revenue growth also has Morgan Stanley retaining an “overweight” rating with a price target of $4.80 on Nufarm shares.  

Will it be flip flops or gummies?

Well, there is no certain correlation between weather and share performance, not that I have discovered as of yet anyway. But there can be implications from various weather events on how a company can carry out its business.

With that being said, if you were still interested, the Bureau of Meteorology is forecasting above-average rainfall for much of the country, better pack the brolly.

More reading

• Can the ugliest ASX 200 dogs of 2020 turnaround in the New Year?
• These ASX dividend shares offer investors attractive yields
• Leading brokers name 3 ASX shares to buy today
• 3 AGM highlights lifting the Nufarm (ASX:NUF) share price today
• Why Bapcor, Fortescue, Nufarm, & Saracen shares are pushing higher

Motley Fool contributor Mitchell Lawler owns shares of Elders Limited. The Motley Fool Australia has recommended Elders Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Rain or shine for these 3 ASX agricultural shares appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/37XWTTo

With term deposits offering only paltry interest rates, income investors are turning to the share market for yield.

If you’re one of them, then you might want to take a closer look at the dividend shares listed below:

Accent Group Ltd (ASX: AX1)

The first dividend share to look at is Accent. It is the leading footwear retailer behind a number of popular store brands. These include HYPE DC, Platypus, The Athlete’s Foot, and Sneaker Lab. Accent has also recently launched two new store brands– Australian Stylerunner and Pivot.

Pleasingly, although a pandemic is not necessarily the best time to launch a new retail brand, this hasn’t stopped these new brands from thriving. Management revealed that these new stores have been materially outperforming expectations since opening. This bodes well for its bold expansion plans over the coming years.

According to a note out of Morgan Stanley, it expects the company to pay a fully franked dividend of 9.4 cents per share in FY 2021. Based on the latest Accent share price, this represents a 4% dividend yield.

Aventus Group (ASX: AVN)

Another dividend share to look at is Aventus. It is the owner and operator of 20 large format retail parks across Australia. It counts major retailers such as ALDI, Bunnings, Officeworks, and The Good Guys as tenants.

This is positive for two reasons. Not only has this supported high occupancy levels, these tenancies give the company’s centres a high weighting towards everyday needs. This has proven to be a real strength during the pandemic and allowed Aventus to collect the majority of its rent as normal in FY 2020.

Analysts at Macquarie are positive on the company and believe it will pay a 16.7 cents per share dividend in FY 2021. Based on the latest Aventus share price, this represents a forward 6% dividend yield.

More reading

• Why did the Accent (ASX:AX1) share price defy the odds in 2020?
• Why Afterpay (ASX:APT) and these ASX shares just hit 52-week highs or better
• These are the 7 best ASX retail shares in 2020
• Here’s what these popular ASX dividend shares plan to pay investors in 2021
• 2 ASX dividend shares with attractive yields

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group and AVENTUS RE UNIT. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Smash term deposits with these ASX dividend shares appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34VTPW8

On Wednesday the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped lower. The benchmark index fell 0.3% to 6,682.4 points.

Will the market be able to bounce back from this on Thursday? Here are five things to watch:

ASX 200 futures pointing higher.

The Australian share market looks set to bounce back on Thursday. According to the latest SPI futures, the ASX 200 is expected to open the day 6 points or 0.1% higher this morning. This follows a positive night on Wall Street which in late trade sees the Dow Jones up 0.3%, the S&P 500 up 0.2%, and the Nasdaq 0.3% higher.

Oil prices higher.

Energy producers such as Oil Search Limited (ASX: OSH) and Santos Ltd (ASX: STO) could be on the rise today after oil prices pushed higher. According to Bloomberg, the WTI crude oil price is up 0.7% to US$48.34 a barrel and the Brent crude oil price has risen 0.3% to US$51.23 a barrel. A decent U.S. inventory draw helped support prices.

UK approves AstraZeneca-Oxford University COVID vaccine.

The United Kingdom has become the first country to approve the COVID-19 vaccine developed by Oxford University and AstraZeneca for emergency use. Trials have shown that the vaccine is safe and about 70% effective against the virus, though AstraZeneca believes that its true efficacy is much stronger. This could be good news for the CSL Limited (ASX: CSL) share price. The biotech giant is already manufacturing millions of doses of this vaccine in Melbourne.

Gold price rises.

Gold miners such as Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) could finish the shortened week strongly. According to CNBC, the spot gold price has risen 0.7% to US$1,896 an ounce. The gold price firmed up after the U.S. dollar sank to a multi-year low.

Early close.

The Australian share market will be closing early on Thursday ahead of the New Years break. According to the ASX, normal trading will cease at 14:10 Sydney time. After which, the market will be reopening as normal again on Monday of next week.

More reading

• ASX 200 drops lower
• Could inflation be coming in 2021?
• Can these 2 outperforming ASX gold miners shine on through 2021?
• Can the ugliest ASX 200 dogs of 2020 turnaround in the New Year?
• Is the surging Bitcoin an existential threat to ASX gold miners?

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34YOptn

The S&P/ASX 200 Index (ASX: XJO) fell by around 0.3% today to 6,682 points.

Here are some of the highlights from the ASX:

Integrated Research Limited (ASX: IRI)

The Integrated Research share price fell 13.25% today after giving investors an update.

The company reminded investors that it had made a continuous disclosure announcement on 18 December 2020 providing revenue and profit estimates for the half year ending 31 December 2020. At the time, Integrated Research said that the range of estimates for revenue and profit were wide because of the unpredictability of business closure in the remaining weeks of December.

The trading performance since that announcement has been below expectations with a continuation of customers deferring purchasing decisions. As a consequence, the company has revised its estimates downwards.

Integrated Research said that it’s anticipating revenue for the first half to be in the range of $34 million to $37 million, compared to $53.2 million for the prior corresponding period.

Profit for the first half is anticipated to be in the range of breakeven to $2 million, down from $11.8 million in the prior corresponding period.

Integrated Research anticipates making a further update on the unaudited results before mid-January with the half-year result expected to be announced on 18 February 2021.

Cooper Energy Ltd. (ASX: COE) and APA Energy (ASX: APA)

Cooper Energy confirmed today that the remaining Sole gas sales agreements (GSAs) will commence on 1 January 2021. Sole gas is processed at the Orbost Gas Processing Plant (OGPP) operated by APA Group.

The long-term GSAs with utility and industrial customers total 19.75 PJ (petajoules) annual contract quantity in 2021. The take-or-pay obligations are a minimum quantity of approximately 90% of the total annual contracted volume.

The commencement of these remaining GSAs means that most Sale gas will now be sold at agreed term contract prices. Prior to commencement of the GSAs, Sole gas was being sold at lower spot prices, less transportation costs, with revenue and costs shared between Cooper Energy and APA as per a previous agreement.

Cooper Energy managing director David Maxwell said: “The commencement of the Sole GSAs is a significant milestone which will deliver a material step-change in production, revenue, cash flow and earnings.

“We are pleased to be increasing gas supply to our utility and industrial customers and providing a competitive new source of gas to the domestic market. We are grateful for the strong support shown by our customers during what has been a longer than expected commissioning phase for the Orbost Gas Processing Plant.”

Other major movers

It was a quiet news day on the ASX 200 today.

The worst performers were: the Growthpoint Properties Australia Ltd (ASX: GOZ) share price which fell 4.3%, the Afterpay Ltd (ASX: APT) share price fell 3.6%, the Spark Infrastructure Group (ASX: SKI) share price dropped 3.2%, the APA Group share price dropped 2.9% and the Bravura Solutions Ltd (ASX: BVS) share price declined 2.7%.

At the top end of the ASX 200 performance table, the United Malt Group Ltd (ASX: UMG) share price rose 2.7%, the Sims Ltd (ASX: SGM) share price rose 2.5%, the Abacus Property Group (ASX: ABP) share price went up 2.4%, the Boral Limited (ASX: BLD) share price rose 2.3% and the Beach Energy Ltd (ASX: BPT) share price grew 2.2%.

More reading

• Could inflation be coming in 2021?
• If you thought 2020’s tech share rally was impressive, hold on for 2021!
• Here are 6 of the top performing ASX fintech shares of 2020
• Why Afterpay, DEXUS, Integrated Research, & Regis Healthcare are dropping lower
• Can the ugliest ASX 200 dogs of 2020 turnaround in the New Year?

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd. The Motley Fool Australia owns shares of AFTERPAY T FPO and APA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post ASX 200 drops lower appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3rHek2i